References in periodicals archive ?
The company said it acquired Inderal XL from Cranford Pharmaceuticals LLC and InnoPran XL from Holmdel Pharmaceuticals LP.
Under the terms of an agreement, ANI's acquired assets include the NDA and trademark for InnoPran XL, including a license to an Orange Book listed patent as well as a distribution license and trademark for Inderal XL as well as finished goods inventory of both products.
Currently, Inderal XL and InnoPran XL are available in 80mg and 120mg sustained release capsules and are indicated for hypertension.
In conjunction, Inderal XL and InnoPran XL have generated combined sales of USD23.
The company recently received FDA approval for InnoPran XL, the first bedtime dosed beta-blocker for the treatment of hypertension.